September 20, 2017 — Catheter ablation to treat an irregular heartbeat, which limits or eliminates patients’ exposure to radiation, should be more widely adopted by physicians, according to a new review article.

Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress, Sept. 16-20 in Copenhagen, Denmark.

Leipzig Interventional Course

ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of Nuclear Cardiology’s (ASNC) 22nd Annual Scientific Session, Sept. 14-17 in Kansas City, Mo. ScImage, provider of scalable web-based image and information management systems, has teamed with Invia, a cardiology imaging software solutions provider, to enable users of ScImage’s Picom365 Enterprise PACS (picture archiving and communication system) seamless access to 4DM. Users of Picom365 will now have access to 4DM’s advanced quantification capabilities as part of their on-premises, cloud or hybrid enterprise solution.

The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is set to grow from $3.7 billion in 2016 to around $16.1 billion by 2026, according to research and consulting firm GlobalData. This represents an impressive compound annual growth rate of 15.7 percent.

CZT SPECT camera detectors offered by GE.

Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently started a transformation with new technologies, protocols and applications. This is partly due to the availability of technologies, concerns about dose, competition, reimbursement and concerns over isotope availability. 

Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its technology in Europe.

September 18, 2017 — Corindus Vascular Robotics Inc. announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the company's second-generation CorPath GRX System.

Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating the efficacy of Philips Spectranetics' Stellarex .035-inch drug-coated balloon (DCB) for peripheral arterial disease (PAD) in comparison to uncoated balloon angioplasty. Marianne Brodmann, M.D., of the Medical University of Graz in Austria, presented the data as a late-breaking trial at the Vascular Interventional Advances (VIVA 17) Annual Conference, Sept. 11-14 in Las Vegas.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now